🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the pharmacokinetics of FF, UMEC and VI administer...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-07-15
Trial ID
NCT01894386
Treatments Being Tested
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-13
Trial ID
NCT02924688
The main purpose of the study is to assess the burden of illness for, COPD ...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-05-31
Trial ID
NCT03543176
GSK573719 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-21
Trial ID
NCT00515502
Treatments Being Tested
This is a multicenter, randomized, double-blind, double-dummy, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-03-01
Trial ID
NCT01817764
Treatments Being Tested
Umeclidinium/vilanterol (UMEC/VI) is a combination product under developmen...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-13
Trial ID
NCT01879410
Asthma is a common, chronic respiratory disease affecting 1-18 percent of t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-01-18
Trial ID
NCT03376932
The purpose of this study is to evaluate the dose-response of 4 doses of um...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-01
Trial ID
NCT02164539